Summit, New Jersey August 2021 – Anthony M. Gruppuso has joined the litigation team as a partner at New Jersey business law firm Brown Moskowitz & Kallen, P.C. Mr. Gruppuso will focus on dispute resolution and litigation for a clientele that includes professional services firms, trustees, medical practices, limited liability company members, manufacturers and distributors, and high net worth individuals.
Brown Moskowitz & Kallen, P.C. Represents Gold Ventures and Capstone Realty Group in the Acquisition of 30 Two Bridges in Fairfield, NJ
Brown Moskowitz & Kallen, P.C. represented Gold Ventures and Capstone Realty Group in the $10,150,000 acquisition of 30 Two Bridges Road in Fairfield, New Jersey, a Class A, 93,260-square-foot office building. The building is situated at the juncture of Routes 80 and 46.
Brown Moskowitz & Kallen, P.C. Represents California-Based Randall Farms in Acquisition by Los Angeles Private Equity Firm Highwiew Capital
Brown Moskowitz & Kallen, P.C. recently represented Vernon, California-based poultry and meat provider Randall Farms and its owners, the Bloom family, in connection with the sale of its assets excluding real estate, which the Bloom family retained. Read More
Brown Moskowitz & Kallen Commercial Transactions Practice Reports Over a Quarter-Billion Dollars in M&A Activity in 2020
Brown Moskowitz & Kallen, P.C. has reported that its Commercial Transactions Group will complete 2020 with more than a quarter-billion dollars in successful merger and acquisition transactions on behalf of a diverse clientele.
Brown Moskowitz & Kallen, P.C. Leads Bi-Coastal Transaction Representing Wytech Industries, Inc. in its Sale to Vance Street Capital, LLC
Kenneth L. Moskowitz Interviews James G. Mottola of Porzio Compliance Services
Join founding partner Kenneth L. Moskowitz for a topical interview with James G. Mottola, Vice President for Data Security and Investigations with Porzio Compliance Services, as they explore critical issues concerning corporate data security…
BMK Partner Rich West interviews Susan Patterson, RN, a Traveling Nurse During the COVID-19 Pandemic
BMK Partner Richard A. West interviews traveling hospital nurse Susan Patterson about her experiences on the front lines of the COVID-19 pandemic in Spring 2020.
Sexual Misconduct and Abuse Crackdown by New Jersey Board of Massage and Bodywork Therapy Results in License Revocations
By Richard A. West, Esq.
Last week, the Division of Consumer Affairs (“the Division”) announced that the New Jersey Board of Massage and Bodywork Therapy (“the Board”) has permanently revoked the license of a massage therapist who engaged in inappropriate and unwanted sexual contact with a female client during a massage session at an Atlantic County spa. The massage therapist is barred from ever working again in the State of New Jersey under a Final Order filed by the Board, the third instance in 2020 of permanent revocation of the license of massage therapist due to sexual misconduct and the ninth such revocation in the past 12 months in the state of New Jersey. This action follows actions by other professional licensing boards and the Attorney General.
New Jersey Division of Consumer Expands Scope of Telemedicine to Include Management of Patients with Chronic Pain and Those Who Qualify for Medical Marijuana
By Richard A. West, Esq.
New Jersey Division of Consumer Affairs Expands Access to Telemedicine Services, Including for Chronic Pain Patients and Patients Who Qualify for Medical Marijuana
The State of New Jersey continues to increase access to telehealth services during the COVID-19 pandemic. Earlier this month, the Division of Consumer Affairs announced expansion of telemedicine protocols, including for patients in treatment for chronic pain and those qualifying for medical marijuana therapy.
An Administrative Order, effective immediately, signed by the Acting Director of the Division, has temporarily waived various regulatory requirements for in-person medical evaluations when providers prescribe controlled dangerous substances (“CDS”) in the treatment of chronic pain or authorize medical marijuana. The action is the latest effort the Division has made in response to Governor Murphy’s March 20th directive to enable broad access to telehealth and telemedicine with the goal of reducing the spread of the COVID-19 virus.
From the Division news release: “New Jersey health care practices are again offering in-person services, but telehealth remains an important option for patients and providers,” said Attorney General Gurbir S. Grewal. “Today, we are making it easier for patients to choose telehealth services for any reason, including to avoid an in-person visit due to the continuing risk of COVID-19. Doctors who use telemedicine to prescribe CDS or authorize medical marijuana will be held to the same professional standards as for in-person visits and must comply with all of the important safeguards we have adopted to prevent diversion and misuse.”
The Executive Order allows health care professionals to utilize a telemedicine encounter to satisfy existing requirements for patient physical examinations before authorizing medical marijuana or prescribing, dispensing, or administering CDS. The Order is consistent with guidance from the federal Drug Enforcement Agency (“DEA”), which issued a temporary waiver permitting practitioners to prescribe a Schedule II CDS via telemedicine without an initial in-person examination, provided the prescription is issued for an approved medical purpose. Telemedicine communications are conducted using real-time, audio-visual, two-way interactive system and remain consistent with the required standard of care. Under New Jersey state law, health care professionals are required to discuss the risks and benefits of opioid medications and alternatives, to check the Prescription Monitoring Program, and to adhere to the five-day limit for the treatment of acute pain and the need to tailor subsequent prescribing to the patient’s current needs.
Quoting the Division’s press release: “This action temporarily removes barriers to providing patients with the medications they need to treat chronic pain and other diseases during the COVID-19 crisis,” said Paul R. Rodríguez, Acting Director of the Division of Consumer Affairs. “This will ensure that those in need of vital prescriptions are able to get them, without unnecessarily putting themselves, fellow patients, and their healthcare providers at risk of exposure to COVID-19.”
The Order further allows health care professionals to use telemedicine encounters to conduct patient assessments and treatment plan reviews when continuously prescribing CDS for the management of chronic pain. Health care professionals remain obligated to document the results of patient assessments and treatment plan reviews in the patient record.
Finally, the Order also allows physicians to use telemedicine encounters to satisfy regulatory requirements for the issuance of a certification for the use of medical marijuana. Physicians may conduct a comprehensive medical history and an evaluation via telemedicine to make a diagnosis and manage the treatment of a qualifying condition. The telemedicine encounter must be conducted using an audio-visual, real-time, two-way interactive communication system, and remain consistent with normative care standards. A subsequent authorization for medical marijuana may also be provided via telemedicine if the physician determines that an in-person visit is not required, consistent with the standard of care.
The Order will remain in effect, unless expressly revoked or superseded by a subsequent Administrative Order issued by the Director of the Division of Consumer Affairs, until whichever of the following occurs first: (1) the end of the state of emergency or public health emergency declared by the Governor in Executive Order 103, whichever is later; or (2) the end of the telemedicine allowance designated by the United States Secretary of Health and Human Services on March 16, 2020, based upon the public health emergency declared by the Secretary on January 31, 2020.
The official Administrative Order can be viewed here:
https://www.nj.gov/oag/newsreleases20/AO-Telemedicine-Prescribing.pdf
BMK has been advising licensed professionals in recent months with to regard to myriad issues arising from the COVID-19 crisis. Should you have a question, please contact Brown Moskowitz & Kallen partner Richard A. West at (973) 376-0909 ext. 1126 or mobile: (973) 229-7928.
This article is for informational purposes only and is not intended to constitute, and does not constitute, legal advice.
Brown Moskowitz & Kallen Secures Precedent-Setting Appellate Victory Defeating Board of Education Challenge to Residential Development
Summit, New Jersey July 2020 – In a precedent-setting reported decision, the Appellate Division of the Superior Court of New Jersey accepted the arguments of Brown Moskowitz & Kallen, P.C. partner Richard S. Schkolnick on behalf of client Markim Developers, LLC.